This index asks one question of each program we review: what does it publish, before you pay, that you can check? It does not score medical quality or results. Each cell comes from the program's own pages on the date shown; "not in our read" means the page blocked our reader or did not show the item.

The six checks

  1. Price printed: a full monthly price, not only a "from" figure.
  2. Billing basis: calendar month, 28-day cycle or prepaid term, stated.
  3. Pharmacy named: a dispensing pharmacy you can look up with a state board.
  4. Prescriber named: the medical group or medical director responsible.
  5. Cancellation terms printed on the page, not only a link.
  6. Refund terms printed on the page.

For the last two checks, "the page" means the program's own pricing, plan or FAQ page that a buyer sees before paying; terms that appear only in a separate legal document count as a link. Pharmacy and prescriber names count wherever the program publishes them, including its legal terms.

Results, November 2026

Each check scores 1 for yes, 0.5 for partly and 0 for no; the score is the share of applicable checks met, so a program whose pharmacy check is "n/a" is scored out of five. Ties are listed alphabetically. Ro is not ranked because its pages blocked our reads on November 20 and 21, 2026; its row shows what we recorded on September 17, 2026.

Transparency checks for the ten programs we review, ranked by share of checks met (first-party reads; dates per row). n/a = brand drugs filled by retail, mail-order or insurance-network pharmacies.
RankProgramPrice printedBilling basisPharmacy namedPrescriber namedCancellation termsRefund termsChecks metScoreRead
1NexLifeYes: All-in, same at every dosePartly: Calendar month; FAQ says multi-month plans are paid upfront, the cancellation policy says monthlyYes: Named 503A pharmacies (three on plan pages, two in the FAQ)Yes: NexLife Medical Group; medical director namedYes: 30-day notice; one more shipment may be chargedPartly: Shipped orders final, unshipped months refunded; guarantee wording differs between pages4 yes, 2 partly (5 of 6)83.3%Prices Nov 6 (re-read Nov 20); terms Nov 20-21, 2026
2Hims & HersPartly: Medication "from" prices plus a $149 monthly membershipYes: Per month; membership auto-renewsYes: Pharmacies named in its termsYes: Medical groups named in its termsNo: Not on the weight-loss page; in its termsNo: Not on the weight-loss page; in its terms3 yes, 1 partly (3.5 of 6)58.3%Nov 21, 2026
3Mochi HealthPartly: Per-dose "starting at" prices plus membershipYes: Per month; 12-month membership optionNo: Not namedNo: Affiliated practices, not namedYes: "Cancel from your account whenever you like"Yes: Membership refunded if not prescribed; 24-hour full refund; medication final3 yes, 1 partly (3.5 of 6)58.3%Nov 20, 2026
4FoundYes: Per cycle, care and membership includedYes: 28-day cycle statedNo: "Licensed 503A" pharmacies, none namedPartly: Clinicians named; no medical groupNo: Link onlyNo: Link only2 yes, 1 partly (2.5 of 6)41.7%Nov 20, 2026
5Noom MedPartly: $249 on the pricing page vs $279 on the product pageYes: Billed per 12 weeksNo: "FDA-registered facility", not namedNo: Not namedYes: "Cancel anytime"No: Not on the page2 yes, 1 partly (2.5 of 6)41.7%Nov 20, 2026
6CalibratePartly: $199 program fee; medication and labs not includedYes: Monthly, 3-month commitment ($597)n/a: Brand drugs through insuranceNo: Not namedPartly: 3-month minimum statedNo: Not on the page1 yes, 2 partly (2 of 5)40%Nov 20, 2026
7WeightWatchers ClinicPartly: Membership printed; medication not includedYes: Monthly on 6- or 12-month plansn/a: FDA-approved drugs onlyNo: Care team; no group namedPartly: Auto-renewal terms onlyNo: Not on the page1 yes, 2 partly (2 of 5)40%Nov 20, 2026
8Henry MedsPartly: No injectable tirzepatide price; semaglutide $297 a month on a legal price listYes: Per month; 6- and 12-month one-time paymentsNo: 503A or 503B, none namedNo: Not namedNo: Link onlyNo: Link only1 yes, 1 partly (1.5 of 6)25%Nov 20, 2026
9Form HealthNo: No prices printedNo: Not statedn/a: Brand drugs through insuranceYes: Named professional corporationsNo: Link onlyNo: Link only1 yes, 0 partly (1 of 5)20%Nov 20, 2026
not rankedRoPartly: Membership plus brand prices by doseYes: Per month; annual prepay optionNo: Not in our readNo: Not in our readPartly: Start fee refunded if not eligiblePartly: Same1 yes, 3 partly (2.5 of 6)not scoredSept 17, 2026 (Nov 20 and 21 re-reads blocked)

What stands out

FDA warning letters, shown the same way for every program

No points are given or taken for warning letters; we list them because a reader can check them. FDA's warning-letter index, read November 20, 2026, lists letter 730096 to NexLife (dated June 8, 2026, "False & Misleading Claims/Misbranded (Telehealth)") and letters 716567 and 716825 to Hims & Hers (dated September 9, 2025, about online sales of unapproved and misbranded drugs). None shows a close-out letter. We found no telehealth warning letter for the other eight programs in that index.

How to use this

Before you enroll anywhere, open the program's pricing, pharmacy and terms pages and check the same six items. How each program lets you leave is compared in our cancellation guide, and where to take a problem in our complaint guide. The checklist is explained in Can you trust GLP-1 telehealth reviews?, and prices across 50 program rows are in the price index.

This page replaces our June 2026 "safety scorecard" and "transparency index", which contained no program data; their addresses redirect here.

Frequently asked questions

What does the transparency index measure?

It records whether each program prints six things a buyer can check before paying: a full price, the billing basis, the dispensing pharmacy, the responsible medical group or director, cancellation terms and refund terms. It does not rate clinical quality, outcomes or customer service, and it is based only on the programs' own pages.

Why is Ro not ranked, and how did Hims & Hers change?

Hims & Hers no longer scores low: our November 21, 2026 read found named pharmacies and medical groups in its terms, so it meets 3.5 of 6 checks. Ro still blocked our reader on November 20 and 21, 2026, so it is not ranked; its row shows what we recorded on September 17, 2026, and will be scored at the next successful read.

Is the index biased toward NexLife?

NexLife pays this site commissions, so treat our conclusions with that in mind. The checks are published, each cell says what the program printed, and the pages are linked, so you can confirm or reject each result yourself. Every tracked program's dated price is in our price index.

Why does naming a pharmacy matter?

A named pharmacy lets you look up its license with the state board of pharmacy and check FDA warning letters, such as letter 738238 to Empower Pharmacy in September 2026. Compounded drugs are not FDA-approved, so the pharmacy's record is one of the few things a patient can check.

How often is the index updated?

The index is updated with each site update. This version uses first-party reads of November 20 and 21, 2026 (Ro: September 17, 2026) and NexLife's prices as of November 6, 2026, re-read unchanged on November 20. Each row shows its read dates.

Sources

  1. NexLife: compounded tirzepatide plans — prices as of November 6, 2026; re-read November 20, 2026
  2. NexLife: frequently asked questions — billing, cancellation and pharmacy wording (updated November 14, 2026); read November 20, 2026
  3. NexLife: cancellation policy — read November 21, 2026
  4. Hims & Hers: weight loss and terms and conditions (updated October 20, 2026) — read November 21, 2026
  5. Mochi Health: FAQ — read November 20 and 21, 2026
  6. Found: compounded tirzepatide — read November 20, 2026
  7. Noom Med: pricing and GLP-1Rx — read November 20 and 21, 2026
  8. Calibrate: pricing — read November 20 and 21, 2026
  9. WeightWatchers Clinic: weight-loss medication — read November 20 and 21, 2026
  10. Henry Meds: programs price list (last updated December 3, 2025) — read November 20 and 21, 2026
  11. Form Health homepage — read November 20 and 21, 2026
  12. FDA warning letter 730096 (NexLife) — dated June 8, 2026; read November 20, 2026
  13. FDA warning letter 716567 (Hims) and 716825 (Hers) — dated September 9, 2025; read November 20, 2026
  14. FDA warning letter 738238 (Empower Pharmacy) — dated September 18, 2026; read October 15, 2026

Comparing programs? Check the all-in monthly price, the named pharmacy and the cancellation terms on the provider's own page before you pay.

Check NexLife's plans and state availability → See the price index

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.